$ACOR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACORDA THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACORDA THERAPEUTICS INC. Get notifications about new insider transactions in ACORDA THERAPEUTICS INC for free.
Page: < prev 1 ... 11 12 13 14 15 16 17 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.66 | 100 | 1,566 | 49,015 | 49.1 K to 49 K (-0.20 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.67 | 100 | 1,567 | 49,115 | 49.2 K to 49.1 K (-0.20 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.68 | 300 | 4,704 | 49,215 | 49.5 K to 49.2 K (-0.61 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.69 | 400 | 6,276 | 49,515 | 49.9 K to 49.5 K (-0.80 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.70 | 800 | 12,560 | 49,915 | 50.7 K to 49.9 K (-1.58 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.71 | 100 | 1,571 | 50,715 | 50.8 K to 50.7 K (-0.20 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.72 | 900 | 14,148 | 50,815 | 51.7 K to 50.8 K (-1.74 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.73 | 300 | 4,719 | 51,715 | 52 K to 51.7 K (-0.58 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.74 | 200 | 3,148 | 52,015 | 52.2 K to 52 K (-0.38 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.75 | 400 | 6,300 | 52,215 | 52.6 K to 52.2 K (-0.76 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.76 | 300 | 4,728 | 52,615 | 52.9 K to 52.6 K (-0.57 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.77 | 300 | 4,731 | 52,915 | 53.2 K to 52.9 K (-0.56 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.79 | 200 | 3,158 | 53,215 | 53.4 K to 53.2 K (-0.37 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.80 | 200 | 3,160 | 53,415 | 53.6 K to 53.4 K (-0.37 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.85 | 100 | 1,585 | 53,615 | 53.7 K to 53.6 K (-0.19 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.86 | 100 | 1,586 | 53,715 | 53.8 K to 53.7 K (-0.19 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.89 | 100 | 1,589 | 53,815 | 53.9 K to 53.8 K (-0.19 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.90 | 300 | 4,770 | 53,915 | 54.2 K to 53.9 K (-0.55 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.91 | 100 | 1,591 | 54,215 | 54.3 K to 54.2 K (-0.18 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.92 | 100 | 1,592 | 54,315 | 54.4 K to 54.3 K (-0.18 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.95 | 500 | 7,975 | 54,415 | 54.9 K to 54.4 K (-0.91 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.96 | 300 | 4,788 | 54,915 | 55.2 K to 54.9 K (-0.54 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.00 | 400 | 6,400 | 55,215 | 55.6 K to 55.2 K (-0.72 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 14.88 | 300 | 4,464 | 48,792 | 49.1 K to 48.8 K (-0.61 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 14.92 | 300 | 4,476 | 49,092 | 49.4 K to 49.1 K (-0.61 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 14.94 | 900 | 13,446 | 49,392 | 50.3 K to 49.4 K (-1.79 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 14.98 | 800 | 11,984 | 50,292 | 51.1 K to 50.3 K (-1.57 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 14.99 | 400 | 5,996 | 51,092 | 51.5 K to 51.1 K (-0.78 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.02 | 400 | 6,008 | 51,492 | 51.9 K to 51.5 K (-0.77 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.05 | 300 | 4,515 | 51,892 | 52.2 K to 51.9 K (-0.57 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.07 | 300 | 4,521 | 52,192 | 52.5 K to 52.2 K (-0.57 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.08 | 200 | 3,016 | 52,492 | 52.7 K to 52.5 K (-0.38 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.10 | 200 | 3,020 | 52,692 | 52.9 K to 52.7 K (-0.38 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.11 | 300 | 4,533 | 52,892 | 53.2 K to 52.9 K (-0.56 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.12 | 600 | 9,072 | 53,192 | 53.8 K to 53.2 K (-1.12 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.15 | 200 | 3,030 | 53,792 | 54 K to 53.8 K (-0.37 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.25 | 100 | 1,525 | 53,992 | 54.1 K to 54 K (-0.18 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.27 | 200 | 3,054 | 54,092 | 54.3 K to 54.1 K (-0.37 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.28 | 300 | 4,584 | 54,292 | 54.6 K to 54.3 K (-0.55 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.29 | 200 | 3,058 | 54,592 | 54.8 K to 54.6 K (-0.37 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.30 | 1,400 | 21,420 | 54,792 | 56.2 K to 54.8 K (-2.49 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.31 | 400 | 6,124 | 56,192 | 56.6 K to 56.2 K (-0.71 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.33 | 700 | 10,731 | 56,592 | 57.3 K to 56.6 K (-1.22 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.34 | 100 | 1,534 | 57,292 | 57.4 K to 57.3 K (-0.17 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.35 | 200 | 3,070 | 57,392 | 57.6 K to 57.4 K (-0.35 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.38 | 300 | 4,614 | 57,592 | 57.9 K to 57.6 K (-0.52 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.42 | 200 | 3,084 | 57,892 | 58.1 K to 57.9 K (-0.34 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.43 | 600 | 9,258 | 58,092 | 58.7 K to 58.1 K (-1.02 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.45 | 1,400 | 21,630 | 58,692 | 60.1 K to 58.7 K (-2.33 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.46 | 700 | 10,822 | 60,092 | 60.8 K to 60.1 K (-1.15 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.47 | 1,296 | 20,049 | 60,792 | 62.1 K to 60.8 K (-2.09 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.48 | 709 | 10,975 | 62,088 | 62.8 K to 62.1 K (-1.13 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.49 | 95 | 1,472 | 62,797 | 62.9 K to 62.8 K (-0.15 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.90 | 100 | 1,590 | 55,615 | 55.7 K to 55.6 K (-0.18 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.95 | 100 | 1,595 | 55,715 | 55.8 K to 55.7 K (-0.18 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.98 | 200 | 3,196 | 55,815 | 56 K to 55.8 K (-0.36 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.99 | 600 | 9,594 | 56,015 | 56.6 K to 56 K (-1.06 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.00 | 2,130 | 34,080 | 56,615 | 58.7 K to 56.6 K (-3.63 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.01 | 600 | 9,606 | 58,745 | 59.3 K to 58.7 K (-1.01 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.02 | 1,400 | 22,428 | 59,345 | 60.7 K to 59.3 K (-2.30 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.03 | 3,419 | 54,807 | 60,745 | 64.2 K to 60.7 K (-5.33 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.04 | 1,200 | 19,248 | 64,164 | 65.4 K to 64.2 K (-1.84 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.05 | 3,060 | 49,113 | 65,364 | 68.4 K to 65.4 K (-4.47 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.06 | 1,800 | 28,908 | 68,424 | 70.2 K to 68.4 K (-2.56 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.07 | 2,100 | 33,747 | 70,224 | 72.3 K to 70.2 K (-2.90 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.08 | 1,470 | 23,638 | 72,324 | 73.8 K to 72.3 K (-1.99 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.09 | 1,300 | 20,917 | 73,794 | 75.1 K to 73.8 K (-1.73 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.10 | 500 | 8,050 | 75,094 | 75.6 K to 75.1 K (-0.66 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.11 | 621 | 10,004 | 75,594 | 76.2 K to 75.6 K (-0.81 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.12 | 200 | 3,224 | 76,215 | 76.4 K to 76.2 K (-0.26 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.13 | 200 | 3,226 | 76,415 | 76.6 K to 76.4 K (-0.26 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.14 | 300 | 4,842 | 76,615 | 76.9 K to 76.6 K (-0.39 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.15 | 500 | 8,075 | 76,915 | 77.4 K to 76.9 K (-0.65 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.17 | 200 | 3,234 | 77,415 | 77.6 K to 77.4 K (-0.26 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.50 | 800 | 12,400 | 62,892 | 63.7 K to 62.9 K (-1.26 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.52 | 200 | 3,104 | 63,692 | 63.9 K to 63.7 K (-0.31 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.56 | 400 | 6,224 | 63,892 | 64.3 K to 63.9 K (-0.62 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.57 | 300 | 4,671 | 64,292 | 64.6 K to 64.3 K (-0.46 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.58 | 300 | 4,674 | 64,592 | 64.9 K to 64.6 K (-0.46 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.59 | 200 | 3,118 | 64,892 | 65.1 K to 64.9 K (-0.31 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.60 | 200 | 3,120 | 65,092 | 65.3 K to 65.1 K (-0.31 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.61 | 200 | 3,122 | 65,292 | 65.5 K to 65.3 K (-0.31 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.62 | 301 | 4,702 | 65,492 | 65.8 K to 65.5 K (-0.46 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.63 | 400 | 6,252 | 65,793 | 66.2 K to 65.8 K (-0.60 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.66 | 400 | 6,264 | 66,193 | 66.6 K to 66.2 K (-0.60 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.68 | 300 | 4,704 | 66,593 | 66.9 K to 66.6 K (-0.45 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.69 | 800 | 12,552 | 66,893 | 67.7 K to 66.9 K (-1.18 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.70 | 1,549 | 24,319 | 67,693 | 69.2 K to 67.7 K (-2.24 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.71 | 351 | 5,514 | 69,242 | 69.6 K to 69.2 K (-0.50 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.72 | 2,300 | 36,156 | 69,593 | 71.9 K to 69.6 K (-3.20 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.73 | 111 | 1,746 | 71,893 | 72 K to 71.9 K (-0.15 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.74 | 200 | 3,148 | 72,004 | 72.2 K to 72 K (-0.28 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.75 | 1,388 | 21,861 | 72,204 | 73.6 K to 72.2 K (-1.89 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.76 | 100 | 1,576 | 73,592 | 73.7 K to 73.6 K (-0.14 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.79 | 300 | 4,737 | 73,692 | 74 K to 73.7 K (-0.41 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.80 | 200 | 3,160 | 73,992 | 74.2 K to 74 K (-0.27 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.82 | 100 | 1,582 | 74,192 | 74.3 K to 74.2 K (-0.13 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.89 | 900 | 14,301 | 74,292 | 75.2 K to 74.3 K (-1.20 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.90 | 400 | 6,360 | 75,192 | 75.6 K to 75.2 K (-0.53 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.91 | 500 | 7,955 | 75,592 | 76.1 K to 75.6 K (-0.66 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.92 | 600 | 9,552 | 76,092 | 76.7 K to 76.1 K (-0.78 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.96 | 1,000 | 15,960 | 76,692 | 77.7 K to 76.7 K (-1.29 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.97 | 300 | 4,791 | 77,692 | 78 K to 77.7 K (-0.38 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.00 | 800 | 12,800 | 77,992 | 78.8 K to 78 K (-1.02 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.98 | 400 | 6,392 | 78,792 | 79.2 K to 78.8 K (-0.51 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 15.99 | 300 | 4,797 | 79,192 | 79.5 K to 79.2 K (-0.38 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.00 | 1,911 | 30,576 | 79,492 | 81.4 K to 79.5 K (-2.35 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.01 | 800 | 12,808 | 81,403 | 82.2 K to 81.4 K (-0.97 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.02 | 2,000 | 32,040 | 82,203 | 84.2 K to 82.2 K (-2.38 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.03 | 4,417 | 70,805 | 84,203 | 88.6 K to 84.2 K (-4.98 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.04 | 1,200 | 19,248 | 88,620 | 89.8 K to 88.6 K (-1.34 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.05 | 3,850 | 61,793 | 89,820 | 93.7 K to 89.8 K (-4.11 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.06 | 1,900 | 30,514 | 93,670 | 95.6 K to 93.7 K (-1.99 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.07 | 2,022 | 32,494 | 95,570 | 97.6 K to 95.6 K (-2.07 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.08 | 1,400 | 22,512 | 97,592 | 99 K to 97.6 K (-1.41 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.09 | 1,600 | 25,744 | 98,992 | 100.6 K to 99 K (-1.59 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.10 | 300 | 4,830 | 100,592 | 100.9 K to 100.6 K (-0.30 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.11 | 800 | 12,888 | 100,892 | 101.7 K to 100.9 K (-0.79 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.12 | 200 | 3,224 | 101,692 | 101.9 K to 101.7 K (-0.20 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.13 | 400 | 6,452 | 101,892 | 102.3 K to 101.9 K (-0.39 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.14 | 700 | 11,298 | 102,292 | 103 K to 102.3 K (-0.68 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.15 | 600 | 9,690 | 102,992 | 103.6 K to 103 K (-0.58 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 16.22 | 200 | 3,244 | 103,592 | 103.8 K to 103.6 K (-0.19 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 15.96 | 600 | 9,576 | 117,230 | 117.8 K to 117.2 K (-0.51 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 15.98 | 200 | 3,196 | 117,830 | 118 K to 117.8 K (-0.17 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 15.99 | 1,900 | 30,381 | 118,030 | 119.9 K to 118 K (-1.58 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 16.00 | 2,800 | 44,800 | 119,930 | 122.7 K to 119.9 K (-2.28 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 16.01 | 1,200 | 19,212 | 122,730 | 123.9 K to 122.7 K (-0.97 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 16.02 | 2,203 | 35,292 | 123,930 | 126.1 K to 123.9 K (-1.75 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 16.03 | 8,797 | 141,016 | 126,133 | 134.9 K to 126.1 K (-6.52 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 16.04 | 3,400 | 54,536 | 134,930 | 138.3 K to 134.9 K (-2.46 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 16.05 | 3,611 | 57,957 | 138,330 | 141.9 K to 138.3 K (-2.54 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 16.06 | 3,900 | 62,634 | 141,941 | 145.8 K to 141.9 K (-2.67 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 16.07 | 4,959 | 79,691 | 145,841 | 150.8 K to 145.8 K (-3.29 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 16.08 | 1,900 | 30,552 | 150,800 | 152.7 K to 150.8 K (-1.24 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 16.09 | 1,230 | 19,791 | 152,700 | 153.9 K to 152.7 K (-0.80 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 16.10 | 300 | 4,830 | 153,930 | 154.2 K to 153.9 K (-0.19 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 16.11 | 1,000 | 16,110 | 154,230 | 155.2 K to 154.2 K (-0.64 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 16.12 | 700 | 11,284 | 155,230 | 155.9 K to 155.2 K (-0.45 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 16.13 | 100 | 1,613 | 155,930 | 156 K to 155.9 K (-0.06 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 16.14 | 400 | 6,456 | 156,030 | 156.4 K to 156 K (-0.26 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 16.15 | 200 | 3,230 | 156,430 | 156.6 K to 156.4 K (-0.13 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 16.17 | 300 | 4,851 | 156,630 | 156.9 K to 156.6 K (-0.19 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | FISHER MARY | Chief Operating Off ... | Sell | S | 16.20 | 300 | 4,860 | 156,930 | 157.2 K to 156.9 K (-0.19 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 15.97 | 300 | 4,791 | 49,377 | 49.7 K to 49.4 K (-0.60 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 15.99 | 200 | 3,198 | 49,677 | 49.9 K to 49.7 K (-0.40 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.00 | 1,100 | 17,600 | 49,877 | 51 K to 49.9 K (-2.16 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.01 | 100 | 1,601 | 50,977 | 51.1 K to 51 K (-0.20 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.02 | 987 | 15,812 | 51,077 | 52.1 K to 51.1 K (-1.90 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.03 | 3,113 | 49,901 | 52,064 | 55.2 K to 52.1 K (-5.64 %) |